What is the focus of USP 797?

The focus of USP 797 is on sterile compounding. This set of guidelines ensures that sterile compounded preparations are prepared in a manner that minimizes the risk of contamination and ensures patient safety. It covers various aspects of sterile compounding, including the standards for environments, equipment, and procedures that pharmacies must follow to maintain sterility and mitigate risks associated with the preparation of sterile products.

The guidelines detailed in USP 797 are critical for settings such as hospitals and outpatient facilities where sterile drug preparations are often necessary, for instance in the preparation of injections or infusions. By adhering to these standards, pharmacists can help ensure that compounded sterile products are safe, effective, and of high quality.

Understanding the specific focus on sterile compounding in USP 797 highlights the importance of strict quality control measures in pharmacy practice, particularly those involved in preparing medications that are administered directly into patients' bodies. This is crucial for preventing infections or adverse reactions that may arise from improperly compounded sterile preparations.